- Home
- HUMA vs NATH Comparison
HUMA vs NATH Comparison
Compare HUMA & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- NATH
- Stock Information
- Founded
- HUMA 2004
- NATH 1916
- Country
- HUMA United States
- NATH United States
- Employees
- HUMA N/A
- NATH N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- HUMA Health Care
- NATH Consumer Discretionary
- Exchange
- HUMA Nasdaq
- NATH Nasdaq
- Market Cap
- HUMA 427.2M
- NATH 385.4M
- IPO Year
- HUMA N/A
- NATH N/A
- Fundamental
- Price
- HUMA $1.68
- NATH $93.98
- Analyst Decision
- HUMA Strong Buy
- NATH
- Analyst Count
- HUMA 6
- NATH 0
- Target Price
- HUMA $14.60
- NATH N/A
- AVG Volume (30 Days)
- HUMA 6.6M
- NATH 11.0K
- Earning Date
- HUMA 05-09-2025
- NATH 06-11-2025
- Dividend Yield
- HUMA N/A
- NATH 2.15%
- EPS Growth
- HUMA N/A
- NATH 24.88
- EPS
- HUMA N/A
- NATH 5.80
- Revenue
- HUMA N/A
- NATH $146,386,000.00
- Revenue This Year
- HUMA N/A
- NATH N/A
- Revenue Next Year
- HUMA $1,178.15
- NATH N/A
- P/E Ratio
- HUMA N/A
- NATH $16.20
- Revenue Growth
- HUMA N/A
- NATH 6.83
- 52 Week Low
- HUMA $1.15
- NATH $64.02
- 52 Week High
- HUMA $9.97
- NATH $104.96
- Technical
- Relative Strength Index (RSI)
- HUMA 38.93
- NATH 51.16
- Support Level
- HUMA $1.43
- NATH $92.64
- Resistance Level
- HUMA $1.62
- NATH $95.00
- Average True Range (ATR)
- HUMA 0.18
- NATH 3.33
- MACD
- HUMA 0.07
- NATH 0.06
- Stochastic Oscillator
- HUMA 70.67
- NATH 66.44
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.